First off, ARYC. Wow! This one STORMED OUT OF THE GATES today! Flying up 70% at the open and closing up 31%. There is surely a buying panic now for shares of this potentially enourmous Long FDA Pharma Play! Now that the market has become aware of this gem and the excellent product Arrayit Corp. is bringing to the medical world, we foresee continued momentum going forward and will of course, keep you all updated on the progress.
Many of you asked us today, What's going on with POZN? Well simply, we believe it was just a sell on news situation. We definitely did not foresee it, especially since the early morning Pre-Market trading looked so promising. However we still obviously believe the selling will be over soon and continued strong uptrend will come. Here is how one analyst put it...link: http://www.schaeffersresearch.com/commentary/content/on+the+radar+allos+therapeutics+inc+pozen+inc+and+keryx+biopharmaceuticals/trading_floor_blog.aspx?single=true&blogid=99613
POZEN Inc. (POZN) has also racked up considerable call volume today. More than 29,000 call have changed hands on POZN, more than quadrupling the stock's daily average of 6,433 contracts. The out-of-the -money May 12.50 call has seen the most action, with about 9,000 contracts trading on open interest of 15,467 contracts.
Technically speaking, the stock has been unable to overcome the 12.50 level, despite the FDA's approval of the company's Vimovo pain drug. Heading into the report, POZN was flooding with call buying, as the stock's ISE/CBOE 10-day call/put volume ratio of 2.49 indicates that calls bought to open more than doubled puts purchased. Given this degree of optimism, the stock could be experiencing a "sell on the news" reaction today.
No comments:
Post a Comment